TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 21823421

Group type: EXPERIMENTAL
Intervention: KXC + MTX
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: KXC
Number of subjects: 240

Group type: COMPARATOR
Intervention: MTX
Number of subjects: 240
Study: 18281410

Group type: EXPERIMENTAL
Intervention: Fluoxetine
Number of subjects: 102

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Fluoxetine (stricter definition)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Placebo (stricter definition)
Number of subjects: 102
Study: 16688999

Group type: EXPERIMENTAL
Intervention: Chinese herbal medicine for Yiqi Yangyin Quyu (YYQ) and prednisone
Number of subjects: 62

Group type: COMPARATOR
Intervention: Prednisone alone (control group)
Number of subjects: 62
Study: 12926117

Group type: EXPERIMENTAL
Intervention: Postoperative adjuvant therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Preoperative approach
Number of subjects: 0
Study: 10615946

Group type: EXPERIMENTAL
Intervention: Triglyceride infusion
Number of subjects: 14

Group type: COMPARATOR
Intervention: Triglyceride infusion with hyperinsulinemic clamp
Number of subjects: 14
Study: 9187983

Group type: EXPERIMENTAL
Intervention: Unsupported arm training (ARMT)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Low-intensity resistive breathing training (RBT)
Number of subjects: 26
Study: 1553611

Group type: EXPERIMENTAL
Intervention: Jejunal interposition hepaticoduodenostomy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Roux-en-Y hepaticojejunostomy
Number of subjects: 0
Study: 3884880

Group type: EXPERIMENTAL
Intervention: Ibuprofen
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Naproxen
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Sulindac
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 29182037

Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH) 0.5 mg/kg/day
Number of subjects: 374

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 374

Group type: COMPARATOR
Intervention: Baseline
Number of subjects: 374
Study: 30177485

Group type: EXPERIMENTAL
Intervention: Febuxostat
Number of subjects: 443

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 443
Study: 27043417

Group type: EXPERIMENTAL
Intervention: RT+CR (Resistance Training plus Caloric Restriction)
Number of subjects: 24

Group type: COMPARATOR
Intervention: RT (Resistance Training)
Number of subjects: 24
Study: 24762560

Group type: EXPERIMENTAL
Intervention: BreastCARE intervention
Number of subjects: 1235
Study: 22869571

Group type: EXPERIMENTAL
Intervention: TD-1792 (2 mg/kg i.v. q24h)
Number of subjects: 197

Group type: COMPARATOR
Intervention: Vancomycin (1 g i.v. q12h)
Number of subjects: 197

Group type: EXPERIMENTAL
Intervention: TD-1792
Number of subjects: 197

Group type: COMPARATOR
Intervention: Vancomycin
Number of subjects: 197
Study: 19927154

Group type: EXPERIMENTAL
Intervention: Aliskiren 75 mg once daily, increased to 150 mg and then to 300 mg if needed
Number of subjects: 40
Study: 17621602

Group type: EXPERIMENTAL
Intervention: Propofol 4 mg kg(‐1) h(‐1)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Desflurane 1 MAC in air
Number of subjects: 30
Study: 15809571

Group type: EXPERIMENTAL
Intervention: Dual-task methodology combining cognitive and balance assessments
Number of subjects: 0

Group type: COMPARATOR
Intervention: Single task performance (cognitive and balance tests independently)
Number of subjects: 0
Study: 12441726

Group type: EXPERIMENTAL
Intervention: Sub‐Tenon anesthesia as preemptive analgesia
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (no preemptive analgesia)
Number of subjects: 30
Study: 10850585

Group type: EXPERIMENTAL
Intervention: Preemptive therapy with intravenous ganciclovir and CMV‐hyperimmunoglobulin
Number of subjects: 31

Group type: COMPARATOR
Intervention: Therapy only at onset of clinical symptoms (Control)
Number of subjects: 31
Study: 8712444

Group type: EXPERIMENTAL
Intervention: Epidural meperidine 12.5 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Epidural meperidine 25 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Epidural meperidine 50 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Epidural meperidine 75 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Epidural meperidine 100 mg
Number of subjects: 0
Study: 1922609

Group type: EXPERIMENTAL
Intervention: Captopril
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control (no drug)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Acebutolol
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Prazosin
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Indomethacin
Number of subjects: 8
Study: 6178096

Group type: EXPERIMENTAL
Intervention: Ceruletide (CRL) at a dose of 2 ng/kg/min
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 31160658

Group type: EXPERIMENTAL
Intervention: Uncontrolled SBP (≥140 mm Hg)
Number of subjects: 14598

Group type: EXPERIMENTAL
Intervention: Uncontrolled DBP (≥90 mm Hg)
Number of subjects: 14598

Group type: EXPERIMENTAL
Intervention: Continuous SBP
Number of subjects: 14598

Group type: EXPERIMENTAL
Intervention: Continuous DBP
Number of subjects: 14598

Group type: EXPERIMENTAL
Intervention: Continuous PP
Number of subjects: 14598

Group type: EXPERIMENTAL
Intervention: Continuous MAP
Number of subjects: 14598

Group type: EXPERIMENTAL
Intervention: SBP
Number of subjects: 14598

Group type: EXPERIMENTAL
Intervention: DBP
Number of subjects: 14598

Group type: EXPERIMENTAL
Intervention: PP
Number of subjects: 14598

Group type: EXPERIMENTAL
Intervention: MAP
Number of subjects: 14598
Study: 30477855

Group type: EXPERIMENTAL
Intervention: Mustard (MU)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Ginger (GI)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Warm Water Alone (WA)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Overall warmth
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Skin temperature at the feet
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Skin temperature at the hands
Number of subjects: 17
Study: 26777137

Group type: EXPERIMENTAL
Intervention: Simeprevir 100 mg QD plus PR
Number of subjects: 457

Group type: EXPERIMENTAL
Intervention: Simeprevir 150 mg QD plus PR
Number of subjects: 457

Group type: COMPARATOR
Intervention: Placebo plus PR
Number of subjects: 457
Study: 25103362

Group type: EXPERIMENTAL
Intervention: Rumination on present emotions and thoughts
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Acceptance of whatever thoughts and feelings come up
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 30
Study: 23983966

Group type: EXPERIMENTAL
Intervention: 500 mg/day quercetin
Number of subjects: 941

Group type: EXPERIMENTAL
Intervention: 1000 mg/day quercetin
Number of subjects: 941

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 941
Study: 19497244

Group type: EXPERIMENTAL
Intervention: Olanzapine 10, 20, and 40 mg/day (combined)
Number of subjects: 599

Group type: EXPERIMENTAL
Intervention: Olanzapine (combined)
Number of subjects: 599
Study: 17256809

Group type: EXPERIMENTAL
Intervention: Botulinum toxin injections (30 units Botox or 90 units Dysport)
Number of subjects: 100

Group type: COMPARATOR
Intervention: 0.2% Nitroglycerin ointment applied three times daily for 8 weeks
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Botulinum toxin injections
Number of subjects: 100

Group type: COMPARATOR
Intervention: 0.2% Nitroglycerin ointment
Number of subjects: 100
Study: 16118578

Group type: EXPERIMENTAL
Intervention: Mild, continuous exercise during decompression (fin underwater swimming at about 30% of maximal oxygen uptake)
Number of subjects: 10

Group type: COMPARATOR
Intervention: No exercise during decompression (control)
Number of subjects: 10
Study: 12473548

Group type: EXPERIMENTAL
Intervention: Type 2 diabetes mellitus (type 2D) patients
Number of subjects: 3

Group type: COMPARATOR
Intervention: Essential hypertension (EH) patients
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 3
Study: 9795972

Group type: EXPERIMENTAL
Intervention: Dietary lycopene from tomato juice, spaghetti sauce, and tomato oleoresin for a period of one week each
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Dietary lycopene from spaghetti sauce and tomato oleoresin
Number of subjects: 19

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 19
Study: 8681500

Group type: EXPERIMENTAL
Intervention: Doxazosin (1-8 mg daily)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Enalapril (5-20 mg daily)
Number of subjects: 70
Study: 1977577

Group type: EXPERIMENTAL
Intervention: Low dose oral interferon alpha
Number of subjects: 32

Group type: COMPARATOR
Intervention: Intensive supportive management alone
Number of subjects: 32
Study: 341964

Group type: EXPERIMENTAL
Intervention: Pharmacological doses of oxytocin (2.6 mU/minute increasing to 422.4 mU/minute)
Number of subjects: 278

Group type: COMPARATOR
Intervention: Physiological doses of oxytocin (2.6 to 13.2 mU/minute)
Number of subjects: 278
Study: 31808662

Group type: EXPERIMENTAL
Intervention: Preoperative and postoperative airtest (SpO2 assessment on room air)
Number of subjects: 902

Group type: EXPERIMENTAL
Intervention: Airtest score (based on pre and postoperative SpO2)
Number of subjects: 902
Study: 27584139

Group type: EXPERIMENTAL
Intervention: Home-Based Telemedicine (HBT) program for 6 months
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (no HBT, only recommendation to continue exercising at home)
Number of subjects: 100
Study: 26019465

Group type: EXPERIMENTAL
Intervention: EZ-FIX
Number of subjects: 105
Study: 23849279

Group type: EXPERIMENTAL
Intervention: Households in the top third of monetary expenditures on market foods
Number of subjects: 1199

Group type: COMPARATOR
Intervention: Households that reported not spending money on market foods
Number of subjects: 1199
Study: 22191292

Group type: EXPERIMENTAL
Intervention: Combined oral and IV contrast-enhanced MDCT (Gp1)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Only IV contrast-enhanced MDCT (Gp2)
Number of subjects: 200
Study: 19436042

Group type: EXPERIMENTAL
Intervention: Group A: 20-min consultation from HSCS and leaflets
Number of subjects: 450

Group type: EXPERIMENTAL
Intervention: Group B: 60-min consultation, four weekly appointments with HSCS, and leaflets
Number of subjects: 450

Group type: EXPERIMENTAL
Intervention: Group C: 60-min consultation, four weekly appointments with HSCS, and scheduled appointment at community-based service
Number of subjects: 450

Group type: EXPERIMENTAL
Intervention: Group A: HSCS attendance at 55 weeks
Number of subjects: 450

Group type: EXPERIMENTAL
Intervention: Group B: HSCS attendance at 55 weeks
Number of subjects: 450

Group type: EXPERIMENTAL
Intervention: Group C: HSCS attendance at 55 weeks
Number of subjects: 450
Study: 17352353

Group type: EXPERIMENTAL
Intervention: Burr‐hole irrigation
Number of subjects: 80

Group type: COMPARATOR
Intervention: Burr‐hole drainage
Number of subjects: 80
Study: 15313991

Group type: EXPERIMENTAL
Intervention: Topical diclofenac solution (1.5% wt/wt diclofenac sodium in a carrier containing dimethyl sulfoxide [DMSO])
Number of subjects: 248
Study: 11265924

Group type: EXPERIMENTAL
Intervention: Soft contact lenses worn for up to 13 nights
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Lenses from Gram-negative bacterial carriers
Number of subjects: 20
Study: 9002531

Group type: EXPERIMENTAL
Intervention: RenaGel
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 8288743

Group type: EXPERIMENTAL
Intervention: 100 mg oral melatonin
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 100 mg testosterone propionate i.m. (TP)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 3086959

Group type: EXPERIMENTAL
Intervention: Flunarizine 5 mg a day for patients over 10 kg, 5 mg every two days for patients under 10 kg (3 months)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Flunarizine (3 months)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo (3 months)
Number of subjects: 26
Study: 29091464

Group type: EXPERIMENTAL
Intervention: T-LPP supplement
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 26750458

Group type: EXPERIMENTAL
Intervention: Rotigaptide
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Sodium nitroprusside
Number of subjects: 19
Study: 24269926

Group type: EXPERIMENTAL
Intervention: Methotrexate (initial weekly dose of 10 mg, escalating to 25 mg/week) + infliximab (5 mg/kg body weight at weeks 1, 3, 7, and 14, and every 8 weeks thereafter)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Infliximab alone (5 mg/kg body weight at weeks 1, 3, 7, and 14, and every 8 weeks thereafter)
Number of subjects: 126
Study: 23528365

Group type: EXPERIMENTAL
Intervention: Topical gel with 1% standardized extract of Sphaeralcea angustifolia
Number of subjects: 130

Group type: COMPARATOR
Intervention: Topical gel with 2% diclofenac
Number of subjects: 130
Study: 19393996

Group type: EXPERIMENTAL
Intervention: Laparoscopic cystectomy for endometrioma (group 1)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Three‐step procedure (group 2)
Number of subjects: 20
Study: 18208957

Group type: EXPERIMENTAL
Intervention: Telehomecare units with peripheral devices (blood-pressure monitor, weight scale, glucometer, pulse oximeter) installed in patients' homes, used daily for data collection.
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Telehomecare units
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Telehomecare monitoring
Number of subjects: 22
Study: 12110071

Group type: EXPERIMENTAL
Intervention: Early notification (experimental) group
Number of subjects: 103

Group type: COMPARATOR
Intervention: Delayed notification (control) group
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Combined groups
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Overall response after letters of notification
Number of subjects: 103
Study: 9725415

Group type: EXPERIMENTAL
Intervention: Heartmate left ventricular assist device implantation combined with isolated right coronary artery bypass grafting
Number of subjects: 1

Group type: EXPERIMENTAL
Intervention: Heartmate left ventricular assist device implantation
Number of subjects: 1
Study: 7648106

Group type: EXPERIMENTAL
Intervention: Dopamine (3 micrograms per kg per min for 24 hours)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Dopamine
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control (fluids without dopamine)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Dopamine and Control
Number of subjects: 19
Study: 2670175

Group type: EXPERIMENTAL
Intervention: Methylphenidate
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study: 768471

Group type: EXPERIMENTAL
Intervention: Dramamine
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 30676465

Group type: EXPERIMENTAL
Intervention: Paternal skin-to-skin contact (SSC) shortly after cesarean delivery
Number of subjects: 108

Group type: COMPARATOR
Intervention: Routine care (Control)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Paternal skin-to-skin contact (SSC)
Number of subjects: 108
Study: 28079773

Group type: EXPERIMENTAL
Intervention: Subsequent pregnancies (group B, one; group C, two or greater)
Number of subjects: 426

Group type: EXPERIMENTAL
Intervention: Subsequent pregnancies complicated with GDM
Number of subjects: 426

Group type: COMPARATOR
Intervention: No subsequent pregnancies (group A)
Number of subjects: 426

Group type: EXPERIMENTAL
Intervention: All groups (A, B, C)
Number of subjects: 426
Study: 25484177

Group type: EXPERIMENTAL
Intervention: Crocin (30mg/day; 15mg BID) plus SSRI (fluoxetine 20mg/day or sertraline 50mg/day or citalopram 20mg/day)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo (two placebo tablets per day) plus SSRI (fluoxetine 20mg/day or sertraline 50mg/day or citalopram 20mg/day)
Number of subjects: 40
Study: 23532801

Group type: EXPERIMENTAL
Intervention: 5-grass pollen tablets
Number of subjects: 0
Study: 21252745

Group type: EXPERIMENTAL
Intervention: Letrozole 10 mg daily for 3 days followed by 800 micrograms of vaginal misoprostol
Number of subjects: 168

Group type: COMPARATOR
Intervention: Placebo for 3 days followed by 800 micrograms of vaginal misoprostol
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Letrozole group
Number of subjects: 168

Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 168
Study: 19276230

Group type: EXPERIMENTAL
Intervention: Intralipid infusion to obtain appropriate FFA concentrations
Number of subjects: 8

Group type: COMPARATOR
Intervention: Acipimox to suppress FFA levels
Number of subjects: 8
Study: 17984152

Group type: EXPERIMENTAL
Intervention: Transmural care model
Number of subjects: 62

Group type: COMPARATOR
Intervention: Usual follow-up care
Number of subjects: 62
Study: 15709358

Group type: EXPERIMENTAL
Intervention: Loose larval therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bagged larval therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Hydrogel (standard debridement intervention)
Number of subjects: 0
Study: 11149997

Group type: EXPERIMENTAL
Intervention: Inhaled fluticasone propionate (FP)
Number of subjects: 1034

Group type: COMPARATOR
Intervention: Zafirlukast (ZA)
Number of subjects: 1034
Study: 9389277

Group type: EXPERIMENTAL
Intervention: Granisetron 40 micrograms kg‐1 i.v. before induction of anaesthesia
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 60
Study: 8174433

Group type: EXPERIMENTAL
Intervention: Misoprostol (1200 micrograms/day)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 3659665

Group type: EXPERIMENTAL
Intervention: Analgesics
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 30514630

Group type: EXPERIMENTAL
Intervention: 0.05% atropine eye drops
Number of subjects: 438

Group type: EXPERIMENTAL
Intervention: 0.025% atropine eye drops
Number of subjects: 438

Group type: EXPERIMENTAL
Intervention: 0.01% atropine eye drops
Number of subjects: 438

Group type: COMPARATOR
Intervention: Placebo eye drops
Number of subjects: 438
Study: 29188875

Group type: EXPERIMENTAL
Intervention: Protein-enriched milk (2 x 0.4 L/d)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Isocaloric carbohydrate drink (2 x 0.4 L/d)
Number of subjects: 50
Study: 25803694

Group type: EXPERIMENTAL
Intervention: Web-based assent (n=60)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Paper assent with interspersed quiz questions (n=29)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Paper assent without interspersed quiz questions (n=31)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Full paper group (n=29 + n=31)
Number of subjects: 120
Study: 23135367

Group type: EXPERIMENTAL
Intervention: Caffeine (5 mg·kg)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Lactose (LEx, control)
Number of subjects: 19
Study: 21752522

Group type: EXPERIMENTAL
Intervention: Cryptic shock group (lactate ≥ 4mmol/L and normotension)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Overt shock group (sustained hypotension after fluid challenge)
Number of subjects: 300
Study: 19254586

Group type: EXPERIMENTAL
Intervention: Subcuticular sutures
Number of subjects: 101

Group type: COMPARATOR
Intervention: Staples
Number of subjects: 101
Study: 17299377

Group type: EXPERIMENTAL
Intervention: Hydroxyurea (HU)
Number of subjects: 137
Study: 15116058

Group type: EXPERIMENTAL
Intervention: Gemfibrozil, 600 mg, twice daily for 7 days
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Gemfibrozil
Number of subjects: 20
Study: 11559645

Group type: EXPERIMENTAL
Intervention: Multifaceted educational intervention for general practitioners
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (general practitioners in East Gloucestershire)
Number of subjects: 0
Study: 9756237

Group type: EXPERIMENTAL
Intervention: Research-based practice
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Clinically based research paradigm
Number of subjects: 0
Study: 8186051

Group type: EXPERIMENTAL
Intervention: Hydroxyapatite-coated hip prosthesis
Number of subjects: 0

Group type: COMPARATOR
Intervention: Uncoated, cementless hip prosthesis
Number of subjects: 0
Study: 3555944

Group type: EXPERIMENTAL
Intervention: Phenobarbital (100 mg/day for 2 months)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 29509266

Group type: EXPERIMENTAL
Intervention: Ulinastatin
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control (hip arthroplasty and symptomatic/supportive treatment)
Number of subjects: 80
Study: 27605607

Group type: COMPARATOR
Intervention: Cabergoline (D2 agonist)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Pergolide (D1/D2 agonist)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 24464452

Group type: EXPERIMENTAL
Intervention: Mild/minimal stimulation protocol of recombinant FSH (rFSH) combined with GnRH antagonist (Group A)
Number of subjects: 349

Group type: COMPARATOR
Intervention: Standard long protocol of rFSH combined with GnRH agonist (Group B)
Number of subjects: 349
Study: 23756569

Group type: EXPERIMENTAL
Intervention: Low-fat dairy diet
Number of subjects: 12

Group type: COMPARATOR
Intervention: Fermented dairy diet (yogurt plus cheese)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Non-fermented dairy diet (butter, cream, ice cream)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Full-fat dairy products (fermented and non-fermented)
Number of subjects: 12
Study: 20735258

Group type: EXPERIMENTAL
Intervention: Efavirenz (Arm I)
Number of subjects: 322

Group type: EXPERIMENTAL
Intervention: Ritonavir-boosted atazanavir (Arm II)
Number of subjects: 322

Group type: COMPARATOR
Intervention: Zidovudine/abacavir (Arm III)
Number of subjects: 322
Study: 18327626

Group type: EXPERIMENTAL
Intervention: Biliopancreatic diversion (BPD)
Number of subjects: 290

Group type: EXPERIMENTAL
Intervention: Roux-en-Y gastric bypass (RYGB)
Number of subjects: 290

Group type: EXPERIMENTAL
Intervention: Adjustable gastric banding (AGB)
Number of subjects: 290

Group type: COMPARATOR
Intervention: BPD
Number of subjects: 290

Group type: COMPARATOR
Intervention: RYGB
Number of subjects: 290

Group type: COMPARATOR
Intervention: AGB
Number of subjects: 290
Study: 16484760

Group type: EXPERIMENTAL
Intervention: Web-based supervisor training on worksite mental health
Number of subjects: 189
Study: 12699607

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT) via videoconferencing (VC)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Cognitive-behavioral therapy (CBT) face-to-face (F2F)
Number of subjects: 28